FDA's New Chief Counsel Has Ties To Sharfstein In Baltimore
This article was originally published in The Gray Sheet
Executive Summary
FDA has named Ralph Tyler, currently the insurance commissioner of Maryland, as the agency's new chief counsel
You may also be interested in...
FDA Chief Counsel Ralph Tyler To Depart In August
Ralph Tyler is leaving FDA 18 months after becoming the agency's chief counsel.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.